IncC bla KPC-2 -positive plasmid characterised from ST648 Escherichia coli.
Autor: | Papagiannitsis CC; Department of Microbiology, University Hospital of Larissa, Larissa, Greece., Bitar I; Biomedical Center, Faculty of Medicine and University Hospital in Plzen, Charles University in Prague, Plzen, Czech Republic., Malli E; Department of Microbiology, University Hospital of Larissa, Larissa, Greece., Tsilipounidaki K; Department of Microbiology, University Hospital of Larissa, Larissa, Greece., Hrabak J; Biomedical Center, Faculty of Medicine and University Hospital in Plzen, Charles University in Prague, Plzen, Czech Republic., Petinaki E; Department of Microbiology, University Hospital of Larissa, Larissa, Greece. Electronic address: petinaki@med.uth.gr. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2019 Dec; Vol. 19, pp. 73-77. Date of Electronic Publication: 2019 May 08. |
DOI: | 10.1016/j.jgar.2019.05.001 |
Abstrakt: | Objectives: This study describes the characterisation of type 2 IncC plasmids pC-Ec20-KPC and pC-Ec2-KPC, carrying thebla Methods: E. coli strains Ec-2Lar and Ec-20Lar were recovered from rectal swabs of two patients during monthly surveillance cultures. Transfer experiments by conjugation were carried out using rifampicin-resistant E. coli A15 laboratory strain as recipient. bla Results: Both E. coli isolates, belonging to ST648, transferred bla Conclusion: To our knowledge, this is the first report on complete nucleotide sequences of type 2 IncC plasmids. These findings, which hypothesise the acquisition of KPC-2-encoding transposon Tn4401a by an IncC replicon, indicate the ongoing need for molecular surveillance studies of multidrug-resistant pathogens. In addition, they underline the increasing clinical importance of the IncC plasmid family. (Copyright © 2019. Published by Elsevier Ltd.) |
Databáze: | MEDLINE |
Externí odkaz: |